BlackRock (ALIT holder) discloses 14.7M Alight Inc. Class A shares on 13G/A

BlackRock (CRCT stakeholder) discloses 7.7% beneficial ownership in Cricut Class A

BlackRock Inc. (BLZE) discloses 7.5% beneficial stake in Backblaze Class A

BlackRock (CRDF holder) discloses 863,259 Cardiff Oncology shares in 13G/A

BlackRock, Inc. (ANNX) reports 8.0% beneficial stake in Annexon common stock

BlackRock (CBFV stakeholder) discloses 5.5% CB Financial Services ownership on Schedule 13G

BlackRock discloses 5.3% ownership of ARS Pharmaceuticals (SPRY) common stock

BlackRock (CTRN holder) reports 5.6% beneficial stake in Citi Trends common stock

BlackRock (CFBK holder) discloses 5.1% CF Bankshares stake in Schedule 13G

BlackRock (CTMX holder) discloses 7.6% beneficial stake in CytomX Therapeutics

BlackRock, Inc. (ACHV) discloses 5.1% beneficial stake in Achieve Life Sciences

BlackRock, Inc. (CARR holder) discloses 7.6% Carrier Global ownership on amended 13G

BlackRock (BRZE holder) discloses 7.1% passive stake in Braze Class A

BlackRock (CHRS holder) discloses 8.93M Coherus Oncology shares under sole control

BlackRock (ATEX) discloses 5.1% beneficial stake in Anterix common stock

BlackRock (AOMD) discloses 1.34M-share, 5.4% holding in Angel Oak Mortgage

BlackRock, Inc. (AIP) discloses 6.2% beneficial stake in Arteris shares

BlackRock Inc (AGYS) discloses 4.0M-share, 14.3% ownership in Agilysys

BlackRock Inc. (AVTX) discloses 6.5% Avalo Therapeutics stake on Schedule 13G